Category: Healthcare

Global 3D Printed Drugs Market Key Players Outlook, Latest Trends and Forecast up to 2025

The global 3D printed drugs market was valued at USD 214.3 million in 2017, and is projected to reach USD 295.5 million by 2025, growing at a CAGR of 4.2% during 2018–2025.

Major factors propelling the market growth for 3D printed drugs include technological innovations in 3D printing procedures, user-friendly and easy availability. Moreover, the ability to print drugs on-demand could reduce cost, increase the choice available to clinicians, reduce the risk of counterfeiting, and help personalize drug delivery to the needs of individual patients.

Based on technology type, Fused Deposition Modelling technology is anticipated to lead the market during 2018-2025

Fused Deposition Modelling is expected to hold the largest share in the market during the forecast period due to innovations and technological advancement in the field of pharmaceutical drugs. Inkjet Printer technology type is predicted to exhibit a high growth rate during the forecast period owing to surging adoption among patients due to its characteristics, such as producing 3D Drugs tablets at a constant rate and technologically advanced properties.

Key market players are investing a lot in the research & development activities. The companies are focusing on partnerships for developing 3D printed drugs.

Request for Sample Report https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type/sample-request

The research report global 3D Printed Drugs market provides an in-depth analysis of the 3D printed drugs market, globally, based on technology type and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for 3D drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Request for Customization – https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type/request-for-customization

Key questions answered in this research report:
1. At what pace is the 3D printed drugs market growing worldwide? What will be the growth trend in the future?
2. What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
3. What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the global 3D printed drugs market?
4. What are the various application areas and how they are poised to grow?

For Additional Insights, Click to Access Complete Report –  https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type//

About GMI Research

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition. GMI Research’s leadership team with extensive experience in research and consulting together with our research and domain expertise creates a strong value proposition to create solutions that addresses our client’s business problems and add significant value to long lasting relationship.

The company provides syndicated research report, customized research, sales enablement research, data analytics and KPO (knowledge process outsourcing) service for Electronics & Semiconductors, Information Communication and Technology, Energy & Power, Healthcare, Automotive, Transportation & Logistics and Chemical industries. Our analysts and consultants who are passionate about research and consulting are recruited from renowned local and global universities and have worked with the leading local and international organizations.

Contact Us

Company Name: GMI RESEARCH

Contact Person: Sarah Nash

Email: enquiry@gmiresearch.com

Phone: +353 1 442 8820

Address:Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate

City: Dublin

State: Dublin

Country: Ireland

Website: http://www.gmiresearch.com

Central Fill Pharmacy Automation Market-GMI Research

Central Fill Pharmacy Automation Market-GMI Research

Central Fill Pharmacy Automation Market by Product (Equipment (Workflow management, Automated Dispensing System, Automated Medication Compounding System, Automated Storage and Retrieval Systems and Others), Service (facility design, Process Optimization and Others) and Software), By Vendor (Equipment Vendor and Consulting Vendor) and by Geography – Opportunities & Forecast, 2019-2025

Request Sample : https://tinyurl.com/y3rue3ny

Central fill pharmacy refers to a service where one pharmacy i.e. originating pharmacy requests to prepare a drug order from central fill pharmacy, where drug order is packed after receiving a request with prescription. Drug order packaged by the central fill pharmacy are dispensed directly to the originating pharmacy or patient, who has requested for the drug order at the originating pharmacy. Using Central Fill, pharmacies can aggregate prescriptions from multiple locations and funnel them to a centrally located prescription fulfilment Center.

A jump in the outpatient drug volume is expected due to an aging population with more chronic illness. It can be handled by implementing automation in Central fill pharmacy. The benefits of automation in Central fill pharmacy are reduction in labour costs, reduction in errors, decreased turn around time and more focus on patients. Along with these, technological advancements in this field are giving an opportunity to increase the scalability of business. The above mentioned are the factors which tend to drive the market growth of Central fill pharmacy automation market. Recent trends in the automation market of Central fill pharmacy are the acquiring of Parata by TCGRx, Mckesson Corporation providing customized central fill with its High-volume solutions. However, higher cost of acquisition and installation of equipment can hinder the growth of Central fill pharmacy automation in the market.

Various notable players operating in the market, include McKesson Corporation, TCGRx, Innovation Associates, RxSafe, LLC, R/X Automation Solutions, Capstone Consultants LLC, ARxIUM, Inc., Workflow Solutions, Omnicell, Inc. and ScriptPro

The Central Fill Pharmacy Automation Market has been segmented based on Product, Vendor and key geographies. Based on Product, the market comprises Equipment (Workflow management, Automated Dispensing System, Automated Medication Compounding System, Automated Storage and Retrieval Systems and Others), Service (facility design, Process Optimization and Others) and Software. Based on Vendor, the market comprises of Equipment Vendor and Consulting Vendor. The research report “Central Fill Pharmacy Automation market” provides in-depth analysis of Central Fill Pharmacy Automation market based on Product, Vendor and major geographies for the forecast period from 2019 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the Central Fill Pharmacy Automation market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2019 The competitive landscape section of the report captures and highlights the recent developments in the market.

Request for Customization : https://tinyurl.com/y3vb5asd

Key questions answered in this research report:
1- At what pace is Central Fill Pharmacy Automation market growing? What will be growth trend in future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the Central Fill Pharmacy Automation market?
4- What are the various application areas and how they are poised to grow?

Market Segmentation
• By Product

• Equipment
Workflow management
Automated Dispensing System
Automated Medication Compounding System
Automated Storage and Retrieval Systems
Others

• Service
Facility design
Process Optimization
Others

• Software

• By Vendor
• Equipment Vendor
• Consulting Vendor

By Geography
• North America
As a part of customization
◦ By Product
◦ By Vendor
◦ US
◦ Canada
◦ Mexico

• Europe
As a part of customization
◦ By Product
◦ By Vendor
◦ UK
◦ Germany
◦ Spain
◦ Rest of Europe

• Asia-Pacific
As a part of customization
◦ By Product
◦ By Vendor
◦ China
◦ Australia
◦ India
◦ Rest of APAC

• ROW
As a part of customization
◦ By Product
◦ By Vendor
◦ Brazil
◦ South Africa
◦ GCC countries
◦ Rest of world (remaining countries of the LAMEA region)

Leading market players
• McKesson Corporation
• TCGRx
• Innovation Associates
• RxSafe, LLC
• R/X Automation Solutions
• Capstone Consultants LLC
• ARxIUM, Inc.
• Workflow Solutions
• Omnicell, Inc.
• ScriptPro

*Other prominent players in the market can also be profiled as a part of customization

For more details, Please Visit: https://www.gmiresearch.com/report/central-fill-pharmacy-automation-market/

Contact Sarah Nash
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com

South Africa Ventricular Assist Device Market growing at a CAGR of 9.5%-GMI Research

South Africa Ventricular Assist Device Market growing at a CAGR of 9.5%-GMI Research

GMI Research expects Bridge-to-transplant (BTT) application segment to grow rapidly during the forecast period, growing at a CAGR of 9.5% during 2018–2025 in South Africa

The South Africa Ventricular Assist Device market touched USD XX million by 2025, growing at a CAGR of 11.0% during 2018–2025.

The key factors boosting growth of the market are:
• Increasing number of patients suffering from heart diseases.
• Shortage of heart donors and increase in heart failures.
• Improving healthcare infrastructure in South Africa

Ventricular Assist Device market in South Africa is significantly growing due to rise in transition to minimally invasive surgical procedure from conventional surgeries. Additionally, growing cardiac patient’s pool with heart failures and shortage of heart donors have contributed to the market growth

Left Ventricular Device dominates the market and is expected to do so during the forecast period due to increasing number of left ventricular assist device implantations every year and technological improvements in LVAD implantation procedure. Apart from it the Right Ventricular Device and Biventricular device segment will also see considerable growth rate in the forecast period.

According to GMI Research Bridge-to-transplant application segment held the maximum revenue in 2018 because of increasing patient awareness regarding cardiac diseases, their treatment and devices. Also, shortage of heart donors leads to the alternative method which is installing of VAD in the ventricle. However, the Bride-to-recovery segment is expected to grow in the forecast period due to rise in disposal income and technological advancements in product design.

Key takeaways/key essentials:

  • In 2018, the Bridge-to-transplant application segment held the maximum revenue share in 2018 and will continue to do so in the forecast period.
  • Transcutaneous design type is expected to grow the fastest rate in the forecast period.
  • South Africa is one of the fastest growing economies in the MEA region.

Various notable players operating in South Africa Ventricular Assist Device Market Berlin Heart GmbH, Cardiac Assist, Inc. (LivaNova), HeartWare International, Inc. , Jarvik Heart, Inc., Reliant Heart, Inc., Abbott Healthcare, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation, and Abiomed Inc. among others.

The South Africa Ventricular Assist Device Market has been segmented on the basis of Type, Application, and Design Segmentation. Based on Type, the market comprises of Left Ventricular Device, Right Ventricular Device and Biventricular Device. The Application type includes Bridge-to-transplant (BTT), Bridge-to-recovery (BTR) and Destination Therapy and the Design type includes Implantable Ventricular Assist and Transcutaneous Ventricular Assist Devices

The research report “South Africa Ventricular Assist Device Market” provides in-depth analysis of the Ventricular Assist Device market, in South Africa, based on application type, design type and type for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Ventricular Assist Device Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For more details, Please Visit: https://www.gmiresearch.com/report/south-africa-ventricular-assist-device-vad-market/

Contact Sarah Nash
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com

Penile Implants Market Share, Trends, Growth & Opportunity – GMI Research

Penile Implants Market Share, Trends, Growth & Opportunity – GMI Research

Global Penile Implant Market by Product (Inflatable Penile Implant and Non-Inflatable Implants), By End User (Hospital, Ambulatory Surgical Center, Specialty Clinics) and By Geography – Opportunities & Forecast, 2018-2025

Penile implant is a medical device usually used for treatment of male sexual conditions such as erectile dysfunction, premature ejaculation, treatment resistance impotence, penile disease, etc. The Penile implant is placed inside the penis through invasive or minimally invasive surgical procedure. Penile implants are the most effective treatment for erectile dysfunction. Erectile dysfunction is typically caused by various conditions including congenital anomalies, vascular conditions, Peyronie’s disease, penile or pelvic trauma, and complications in treating prostate cancer.

Request Sample : https://tinyurl.com/y3ewqh4p

Factors such as increasing incidence of penile diseases such as erectile dysfunction, premature ejaculation, etc, increasing awareness about penile diseases and continued adoption of improved penile implant systems are expected to fuel the growth of penile implants market during the forecast period. for instance, As per the National Center for Biotechnology Information, globally around 150 million men and approximately 30 million men in U.S are affected by erectile dysfunction. Moreover, cost effectiveness, minimal recovery time and high rate of patient satisfaction are further expected to boost the penile implants market growth in the coming years. However, side effect associated with these implants, stringent regulation, availability of alternative treatment are factors which restrain the growth of the penile implants market during the forecast period.

Various notable players operating in the market, include American Medical Systems, Coloplast, Promedon, ZEPHYR Surgical Implants, Giant Medical among others. Major players including Coloplast and American Medical Systems are focusing on R&D activities and product launches to hold their leadership in this market.

The global penile implant market report has been segmented based on product type, end user and key geographies. Based on product type, the market comprises inflatable penile implant and non-inflatable implants. The research report “global Penile Implant market” provides in-depth analysis of global penile implant market overview based on product type, end user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides growth, opportunity, market size. trends and forecast for the global penile implant market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Request For Customization : https://tinyurl.com/yyn4rrsb

Key questions answered in this research report:
1- At what pace is penile implant market growing? What will be the Global penile implant Market forecast?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in penile implant and Global penile implant market size?
4- Global penile implant Market outlook, application areas and how they are poised to grow?
5- Global penile implant Market overview, industry analysis and scope of study?

Market Segmentation
By Product Type
• Inflatable Penile Implant
o Three-piece inflatable
o Two-piece inflatable
• Non-Inflatable Implants

By End User
• Hospital
• Ambulatory Surgical Centre
• Specialty Clinics

By Geography
• North America
As a part of customization
o By Product Type
o By End User
o US
o Canada
o Mexico

• Europe
As a part of customization
o By Product Type
o By End User
o UK
o Germany
o Spain
o Rest of Europe

• Asia-Pacific
As a part of customization
o By Product Type
o By End User
o China
o Australia
o India
o Rest of APAC

• ROW
As a part of customization
o By Product Type
o By End User
o Brazil
o South Africa
o GCC countries
o Rest of world (remaining countries of the LAMEA region)

Leading market players
• American Medical Systems
• Coloplast
• Promedon
• ZEPHYR Surgical Implants
• Giant Medical

• *Other prominent vendor or distributor in the market which can be profiled as a part of customization:

For more details, Please Visit: https://www.gmiresearch.com/report/global-penile-implant-market/

Contact Sarah Nash
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820
Email: enquiry@gmiresearch.com